STOCK TITAN

October 2023 Stock Gainers on News, Micro Caps Included

Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.

Data through the session. 22 of 22 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

See the biggest losers of October 2023 Every stock ranked by its October 2023 gain, with or without news

100

Ranked gains

+3972.53%

Largest, TPST

87.9%

Events still above the pre-news close, day +5

18.6%

Median give-back, day +5

Filter and sort
Rows

100 ranked gains in October 2023

Skip the ranked rows and go to the month summary

Every percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.

Rows are ordered by the move measured when the board was ranked. A percentage recomputed from the session's own closing prices can sit a little above or below its neighbours; the rank is the one the measured move gave the row.

Rank Symbol close to close Session Catalyst Announcement
1 TPST under $25M today +3972.53% ‡ against the close of 10/10/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results catalyst from a later release the same session Tempest to Report New and Updated Data from Global Randomized Combination Study of TPST-1120 in First-Line Hepatocellular Carcinoma

16:05 ET after hours

Recomputed from this session's own closing prices: the stored figure of +3970.83% disagrees with them by 1.70 points. The rank is the one the stored figure gave this row.

2 MIRO +216.35% against the close of 10/27/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition United Therapeutics to Acquire Miromatrix Medical

06:00 ET premarket

3 LMDX Also on the opposite board this month on both boards +208.18% against the close of 10/20/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership LumiraDx Partners with AstraZeneca & Everton in the Community to Set Up England’s First Heart & Lung Screening Hub

18:34 ET after hours

4 OPGN +173.81% against the close of 10/11/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution OpGen Enters Into Warrant Inducement Transaction for up to $11.2 Million in Gross Proceeds

12:32 ET intraday

5 SASI +145.45% against the close of 10/12/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Sigma Additive Solutions Announces Signing of Definitive Agreement for NextTrip Acquisition

08:31 ET premarket

6 AKU +144.86% against the close of 10/20/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Akumin Inc. Reaches Agreement with Stonepeak to Become a Private Company

17:00 ET after hours

7 LIAN +117.27% against the close of 10/23/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership LianBio Enters into Agreement with Bristol Myers Squibb for Mavacamten in China and Other Asian Markets

06:59 ET premarket

8 NKTX +112.16% against the close of 10/16/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory catalyst from a later release the same session Nkarta to Host Conference Call on Tuesday, October 17 at 8am ET to Discuss Expansion of Clinical Pipeline and Organizational Cost Measures

16:01 ET after hours

9 ORTX +95.95% against the close of 10/04/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Kyowa Kirin to Acquire Orchard Therapeutics

03:35 ET premarket

10 VERY +94.21% against the close of 10/02/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition iA Financial Group to Acquire Vericity in $170 million Transaction

07:30 ET premarket

11 PHIO under $25M today Also on the opposite board this month on both boards +87.05% against the close of 10/10/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Phio Pharmaceuticals Presents New Data for Targeting of BRD4 with its INTASYL™ Compound PH-894

07:30 ET premarket

12 EDSA +80.74% against the close of 10/11/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Edesa Biotech to Receive Up To C$23 Million in Funding from Federal Government

12:10 ET intraday

13 PRZO under $25M today More than one ranked move this month 2+ ranked moves +79.12% against the close of 10/05/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Australian Regulator Approves First Commercial Drone Flights in Populated Areas and Near People Using ParaZero Safety Systems

07:33 ET premarket

14 ASMB +72.18% against the close of 10/16/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Gilead and Assembly Biosciences Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral Diseases

07:00 ET premarket

15 INM under $25M today Also on the opposite board this month on both boards +70.53% against the close of 10/23/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results InMed Pharmaceuticals Inc.'s INM-901 Demonstrates Unique Pharmacological Effects in Alzheimer's Disease in Preclinical Proof-of-Concept Studies

07:30 ET premarket

16 ICU under $25M today +70.05% against the close of 10/17/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory FDA Grants SeaStar Medical’s Selective Cytopheretic Device Breakthrough Device Designation for Hepatorenal Syndrome

08:30 ET premarket

17 MTC +64.43% against the close of 10/13/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement MMTEC, INC. TO HOLD ITS 2023 ANNUAL MEETING OF SHAREHOLDERS ON NOVEMBER 10, 2023

19:00 ET after hours

18 BTTR under $25M today +57.64% against the close of 10/11/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Better Choice Announces Partnership with Aimia Pet Health to Develop a GLP1 Supplement for its Halo Brand to Combat Obesity in Dogs and Cats

14:45 ET intraday

19 ALXO +56.13% against the close of 10/02/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results ALX Oncology to Host Investor Call and Webcast on October 3, 2023 to Share Interim Phase 2 ASPEN-06 Clinical Trial Results of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer

16:05 ET after hours

20 PEV under $25M today +54.92% against the close of 10/06/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change Phoenix’s EdisonFuture Launches Renewable Solutions for Green Hydrogen Production & Appoints Head of R&D

07:40 ET premarket

21 MNTS +54.75% against the close of 10/11/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Momentus to Provide Delivery Service for RIDE! Space

16:17 ET after hours

22 ACAQ Also on the opposite board this month on both boards +54.44% against the close of 10/10/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Reverse Merger / Shell Athena Consumer Acquisition Corp. Announces Special Meeting Date to Extend the Date by Which Athena Has to Consummate a Business Combination

17:24 ET after hours

23 ABVC +50.59% against the close of 10/25/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement ABVC BioPharma Entered Into a Term Sheet to License Global Rights of CNS Drugs with the Indications of MDD and ADHD to AiBtl BioPharma at the Valuation of $667 Million

08:30 ET premarket

24 BSQR +47.58% against the close of 10/11/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition KONTRON TO ACQUIRE BSQUARE FOR $1.90 PER SHARE

17:05 ET after hours

25 PCTI +47.21% against the close of 10/13/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition PCTEL Announces Definitive Agreement to be Acquired by Amphenol Corporation

20:01 ET after hours

26 RVPH under $25M today +46.40% against the close of 10/27/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Reviva Announces Positive Topline Results from Global Pivotal Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia

07:30 ET premarket

27 PCSA under $25M today +45.41% against the close of 10/12/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Processa Pharmaceuticals to Present at the ThinkEquity Conference

13:08 ET intraday

28 TGH +44.69% against the close of 10/20/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Textainer to be Acquired by Stonepeak for $7.4 Billion

20:00 ET after hours

29 SP +44.65% against the close of 10/04/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Metropolis Technologies, Inc. to Acquire SP Plus Corporation for $1.5 Billion

08:00 ET premarket

30 ACON under $25M today Also on the opposite board this month on both boards +42.86% against the close of 10/24/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to Denver

08:30 ET premarket

31 CDIO under $25M today +41.46% against the close of 10/30/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Cardio Diagnostics Holdings, Inc Receives Innovative Technology Contract from Vizient for Its Novel AI-Driven Precision Heart Disease Tests – Epi+Gen CHD & PrecisionCHD

09:01 ET premarket

32 CVM +41.12% against the close of 10/20/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement 5-Year Head & Neck Cancer Survival Increased From 45% to 73% in CEL-SCI’s Target Population, Cutting Risk of Death in Half, as Presented at Leading Cancer Conference ESMO 2023

09:15 ET premarket

33 INO +41.00% against the close of 10/09/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory INOVIO Receives FDA Feedback that Data from Completed Phase 1/2 Trial of INO-3107 Can Be Used to Submit a BLA Under Accelerated Approval Program

08:00 ET premarket

34 NRDS +40.66% against the close of 10/26/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings NerdWallet Reports Third Quarter 2023 Results

16:05 ET after hours

35 RNAZ +40.39% against the close of 10/23/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results TransCode Therapeutics Announces Preliminary Clinical Results in First Patient in Phase 0 Clinical Study with Lead Therapeutic Candidate, TTX-MC138

08:00 ET premarket

36 MDAI +39.38% against the close of 10/18/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Spectral AI’s DeepView SnapShot® Wound Imaging System, Achieves UKCA Mark and FDA Class 1 Medical Device Classification

08:00 ET premarket

37 INSG +37.10% against the close of 10/30/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change Inseego Corp. Appoints Chief Revenue Officer

16:10 ET after hours

38 LL +36.52% against the close of 10/11/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition catalyst from a later release the same session LL Flooring Confirms Receipt of Unsolicited, Non-Binding Proposal from Live Ventures Incorporated

14:25 ET intraday

39 TTOO Also on the opposite board this month on both boards +35.67% against the close of 10/05/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Guidance Change T2 Biosystems to Report Preliminary Third Quarter 2023 Financial Results and Business Updates on October 12, 2023

16:05 ET after hours

40 NUVL release reads negative +35.57% against the close of 10/03/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Release reads negative, stock rose 35.57% Preliminary Phase 1 Dose-Escalation Data from ALKOVE-1 Trial of NVL-655 Demonstrated Activity in Heavily Pre-Treated Patients with ALK-Positive NSCLC and an ALK-Selective, TRK-Sparing Safety Profile

12:21 ET intraday

41 LOCL under $25M today +34.14% against the close of 10/30/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Local Bounti Announces Third Quarter 2023 Financial Results

16:05 ET after hours

42 OTMO +32.50% against the close of 10/17/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Urgently Announces Anticipated Closing of Merger With Otonomo Technologies

09:15 ET premarket

43 BAER Also on the opposite board this month on both boards +32.27% against the close of 10/23/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution (terminated) Rose on dilution Bridger Aerospace Terminates Proposed Public Offering of its Common Stock

07:30 ET premarket

44 PRZO under $25M today More than one ranked move this month 2+ ranked moves +29.88% against the close of 10/11/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership ParaZero Technologies and Maris-Tech Expand their Collaboration into the Defense Market for Drones

07:55 ET premarket

45 LIPO Also on the opposite board this month on both boards +29.81% against the close of 10/19/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-310 for Oral Lichen Planus

08:00 ET premarket

46 IBRX +29.75% against the close of 10/25/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory FDA Accepts ImmunityBio’s BLA Resubmission as Complete and Sets New PDUFA Date

09:00 ET premarket

47 CZOO +29.55% against the close of 10/11/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings (date set) Cazoo to Announce Third Quarter 2023 Results on October 25, 2023

16:05 ET after hours

48 SRT +29.14% against the close of 10/09/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Startek Announces Agreement to be Acquired by Funds Managed by CSP Management Limited for $4.30 Per Share in Cash

09:25 ET premarket

49 MIND +29.05% against the close of 10/20/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement MIND Technology Announces Order Award

07:00 ET premarket

50 BKYI under $25M today More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards +28.88% against the close of 10/26/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Logistics Provider ALPI Portugal Selects BIO-key for Secure Data Access, Including Multi-factor Authentication and Single Sign-On, Both Internally and for B2B

07:58 ET premarket

51 METC +28.82% against the close of 10/16/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Buyback / Dividend RAMACO RESOURCES PROVIDES UPDATE ON THIRD QUARTER 2023 RESULTS, FULL-YEAR 2023 GUIDANCE, DECLARATION OF FOURTH QUARTER DIVIDENDS, INCREASE IN TRACKING STOCK DIVIDEND AND UPDATE ON RARE EARTH ELEMENT DEVELOPMENT

16:45 ET after hours

52 PSQH under $25M today +28.57% against the close of 10/12/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution PublicSq.’s Form S-1 Goes Effective with SEC

16:15 ET after hours

53 SABS +28.53% against the close of 10/18/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results SAB Biotherapeutics Receives Australian Approval to Commence Phase 1 Clinical Trial of SAB-142, a Potential Disease-Modifying Treatment for Type 1 Diabetes

07:30 ET premarket

54 PWFL +28.43% against the close of 10/09/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Reverse Merger / Shell Powerfleet and MiX Telematics Announce Transformative Business Combination

07:00 ET premarket

55 BCDA under $25M today +28.30% against the close of 10/10/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results BioCardia Announces Completion of Enrollment in Phase III CardiAMP HF Trial and Plans for CardiAMP HF Trial II

06:00 ET premarket

56 HARP Also on the opposite board this month on both boards +27.99% against the close of 10/16/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Harpoon Therapeutics to Host Webcast Reviewing HPN328 Interim Data Presented at ESMO Congress 2023 on October 23, 2023

16:05 ET after hours

57 VERV +27.95% against the close of 10/30/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Verve and Lilly Relationship Expands to Include Verve’s In Vivo Gene Editing Programs Targeting PCSK9 and ANGPTL3

06:01 ET premarket

58 FFIE Also on the opposite board this month on both boards +27.78% against the close of 10/16/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Faraday Future Announces Masterplan to Achieve Sustainability and Further Stability, While Aiming to Reduce Dependence on External Funding Sources

19:28 ET after hours

59 CMTL +27.40% against the close of 10/12/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Stellant Systems, Inc. to Acquire Power Systems Technology Product Line from Comtech

16:01 ET after hours

60 PXMD +26.96% against the close of 10/25/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory PaxMedica Holds Important FDA Type-B Meeting to Review PAX-101 Pivotal Trial Data

08:00 ET premarket

61 SMLP +26.96% against the close of 10/02/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings (date set) Summit Midstream Partners, LP Provides Operational Update, Announces Review of Strategic Alternatives and Schedules Third Quarter 2023 Earnings Call

07:00 ET premarket

62 IMMX +26.61% against the close of 09/29/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Immix Biopharma Announces 72-Patient NXC-201 Clinical Data at the IMS 20th Annual Meeting, 95% Overall Response Rate in Multiple Myeloma

08:06 ET premarket

63 ASPN +26.39% against the close of 10/23/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Guidance Change Aspen Aerogels, Inc. Provides Commercial and Full Year 2023 Financial Outlook Updates

16:30 ET after hours

64 SAVA +25.80% against the close of 10/24/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement MRI Data Suggest Simufilam is Not Associated with Amyloid-related Imaging Abnormalities (ARIA)

09:15 ET premarket

65 EDR +25.62% against the close of 10/25/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Endeavor Announces Review of Strategic Alternatives

16:00 ET after hours

66 BPMC +25.61% against the close of 10/25/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Blueprint Medicines Reports Third Quarter 2023 Results

07:00 ET premarket

67 GTH +25.53% against the close of 10/11/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Genetron Health Enters into Definitive Merger Agreement for Going Private Transaction

16:30 ET after hours

68 AGYS +25.35% against the close of 10/23/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Agilysys Grows Second Quarter Revenue 23% to Record $58.6M

16:05 ET after hours

69 MGRX under $25M today +25.00% against the close of 10/18/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Guidance Change Mangoceuticals, Inc. Provides Update to Shareholders on Q3 Achievements and Guidance on Year End and Near-Term Initiatives

09:00 ET premarket

70 CREX +24.45% against the close of 10/19/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings (date set) Creative Realities Confirms Guidance for 2H2023; Announces Third Quarter 2023 Earnings Conference Call Information

09:00 ET premarket

71 TZOO +24.38% against the close of 10/23/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Travelzoo Reports Third Quarter 2023 Results

06:59 ET premarket

72 BELFB +24.38% against the close of 10/25/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Bel Reports Third Quarter 2023 Results

16:15 ET after hours

73 STKL +24.13% against the close of 10/12/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Guidance Change SunOpta Announces Sale of Frozen Fruit Assets for an Aggregate Purchase Price of $141 Million Along With Preliminary Results for Third Quarter Fiscal 2023 and CFO Transition

07:00 ET premarket

74 TSBX under $25M today +24.12% against the close of 10/27/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. Weber

06:00 ET premarket

75 SLS More than one ranked move this month 2+ ranked moves +23.98% against the close of 10/27/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory SELLAS Life Sciences Receives Fast Track Designation from FDA for SLS009 for Treatment of Relapsed/Refractory Peripheral T-cell Lymphomas

09:03 ET premarket

76 PI +23.87% against the close of 10/25/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Impinj Reports Third Quarter 2023 Financial Results

16:15 ET after hours

77 BFRI under $25M today +23.68% against the close of 10/30/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Rose on dilution Biofrontera Inc. Announces $4.5 Million Registered Direct Offering Priced At-the-market Under NASDAQ Rules

08:01 ET premarket

78 RVMD Also on the opposite board this month on both boards +23.60% against the close of 10/12/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Revolution Medicines Presents Encouraging Clinical Data for RMC-6236 and RMC-6291 at 2023 Triple Meeting

11:50 ET intraday

79 INTZ under $25M today +23.57% against the close of 10/09/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Intrusion Awarded a $5 million Multi-Year Shield Agreement with a Large Telecommunications Provider and Reports Additional Customer Wins

08:00 ET premarket

80 WKSP under $25M today +23.48% against the close of 10/23/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Worksport Increases R&D for Terravis Energy Subsidiary’s Heat Pump Project

08:00 ET premarket

81 VYNE under $25M today +23.39% against the close of 10/27/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results VYNE Therapeutics Announces Positive Data from Phase 1b Trial for Novel BET Inhibitor VYN201 in Patients with Nonsegmental Vitiligo

07:00 ET premarket

82 SPR +23.09% against the close of 10/17/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Spirit AeroSystems, Boeing Reach Agreement to Support Production Stability

07:30 ET premarket

83 SMR +22.86% against the close of 10/05/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Standard Power Chooses NuScale’s Approved SMR Technology and ENTRA1 Energy to Energize Data Centers

06:50 ET premarket

84 PTN under $25M today +22.54% against the close of 10/18/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Guidance Change Palatin Announces Preliminary Quarter Ended September 30, 2023 Vyleesi® Product Revenue Results

07:30 ET premarket

85 NSTG +22.50% against the close of 10/09/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement NanoString Provides Preliminary Financial and Operational Highlights for Third Quarter of 2023

06:00 ET premarket

86 VIGL +22.18% against the close of 10/05/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Vigil Neuroscience to Present at Jefferies Inaugural Biotech CNS/Neuro Summit

16:01 ET after hours

87 BNMV +22.17% against the close of 10/30/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement BitNile Metaverse Announces Name Change to RiskOn International

08:30 ET premarket

88 RAD +21.60% against the close of 10/09/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Creep It Simple: Rite Aid Releases DIY Halloween Costume Recipe Cards

10:00 ET intraday

89 ASTI under $25M today +21.33% against the close of 10/23/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement U.S. Department of Energy Encourages Ascent Solar to Submit Full Application for Federal Funding of Agrivoltaic Product Development Project

16:30 ET after hours

90 BIVI under $25M today +21.32% against the close of 10/27/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement BioVie to Host Conference Call and Webcast Wednesday November 1, 2023 at 8:00 AM ET

08:00 ET premarket

91 VOXX +21.05% against the close of 10/10/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings VOXX International Corporation Reports its Fiscal 2024 Second Quarter Financial Results

16:05 ET after hours

92 SLS More than one ranked move this month 2+ ranked moves +20.93% against the close of 10/12/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results SELLAS Life Sciences Provides Update on Phase 3 REGAL Clinical Trial for Galinpepimut-S in Acute Myeloid Leukemia

16:05 ET after hours

93 ORGN under $25M today +20.84% against the close of 10/10/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Origin Materials Announces Commencement of Commercial-Scale Production at Origin 1

07:00 ET premarket

94 LLAP +20.77% against the close of 10/24/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Terran Orbital Awarded $4.7 Million Contract by European Space Agency

06:30 ET premarket

95 MSGM under $25M today +20.62% against the close of 10/04/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition catalyst from a later release the same session Exclusive Simulation-Style NASCAR® Video Game License Sold to iRacing

09:01 ET premarket

96 EVAX +20.57% against the close of 10/25/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results New and Exciting Clinical Data on Evaxion’s AI-Immunology™-Based Personalized Cancer Vaccines to be Presented

08:30 ET premarket

97 MOVE +20.51% against the close of 10/27/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Movano Health to Launch the Evie Ring on November 20

08:00 ET premarket

98 BKYI under $25M today More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards +20.42% against the close of 10/24/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement BIO-key Sponsors Industry-Leading Cybersecurity Conference, ISC2 Security Congress 2023, in Nashville, TN, October 25 – 27, 2023 (Booth #113)

18:12 ET after hours

99 MGTX +20.27% against the close of 10/27/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership MeiraGTx Announces $30 Million Strategic Investment from Sanofi; Company Pursuing Multiple Additional Strategic Opportunities

07:30 ET premarket

100 XERS +20.25% against the close of 10/13/2023 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Guidance Change Xeris Biopharma Raises Full-Year Financial Guidance and Reaffirms Cash Flow Breakeven in Q4 2023

07:00 ET premarket

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 258 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Exclude the $5M to $25M band

3 events were left out of this board because the measured session set no price of its own, trading either nothing at all or barely moving on an ordinary day's volume, so the figure it would be ranked on is a price carried onto the tape rather than a close.

2 events were left out of this board because the measured session changed hands for less than $25,000 in total, so the percentage prices a handful of shares rather than a move anyone could have taken.

1 event was left out of this board because the ticker had not traded for more than 10 days before the measured session, so no comparable prior close exists.

1 row prints a move recomputed from the session's own closing prices, because the stored figure disagreed with them; each says so on the row, and each keeps the rank the stored figure gave it.

Company names are not shown on months older than a year, because only the current holder of each ticker is known.

In October 2023, the median gainer had given back 18.6% of its move five sessions later; the largest named catalyst was M&A / Acquisition, 15 of the 100 events, at a median of +44.7%, and 27 events fit no named group.

Close-to-close change on the measured trading session, against the previous close.

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.

Which catalysts drove the board

Swipe the table sideways for the day +5 columns.

Catalyst Events Share of board Median move close to close Median at day +5 Still above the pre-news close at day +5
Other Announcement 27 27.0% +25.8% +23.0% 85.2% of 27
M&A / Acquisition 15 15.0% +44.7% +44.0% of 14 100.0% of 14
Clinical Trial Results 14 14.0% +28.4% +34.7% 85.7% of 14
Contract / Partnership 10 10.0% +42.2% +25.6% 90.0% of 10
Earnings 10 10.0% +25.0% +33.9% 100.0% of 10

The day +5 figures are measured over the events in each group that have a five-session close, the count printed beside them, not over every event in the group.

6 other catalyst types, 24 events: FDA & Regulatory, Guidance Change, Offering / Dilution, Leadership Change, Reverse Merger / Shell, Buyback / Dividend.

How much of the move survived

Horizon Still above the pre-news close (close-to-close basis) Median change since the measured close as a share of the move
Day +1 96.0% of 99 0.6% larger move, of 99
Day +5 87.9% of 99 18.6% given back, of 99
Month end 80.4% of 92 27.2% given back, of 92
Month end falls before day +5 for 22 of these 92 events, so this row is not a later horizon than the one above it. 92 of the 100 events have a month-end close later than the measured session; 6 have it on the measured session itself, and 2 have no month-end close.

Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.

Repeat runners

Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.

Moved twice or more inside October 2023

Two or more ranked moves this month, each on a different trading day.

SymbolMeasured sessionsBest move
PRZO 2Other Announcement, Contract / Partnership +79.12%
BKYI 2Other Announcement +28.88%
SLS 2FDA & Regulatory, Clinical Trial Results +23.98%

Also risen on news in earlier months

Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.

SymbolMonthsBest move
TTOOthis month too 2023-09, 2023-08, 2023-07 +65.55%
FEMY 2023-09, 2023-07 +346.32%
CGC 2023-09, 2023-07 +81.37%
FRTX 2023-09, 2023-07 +53.71%
NVOS 2023-09, 2023-08 +63.61%
NKLA 2023-09, 2023-07 +60.87%
FFIEthis month too 2023-09, 2023-08 +31.96%
XOS 2023-09, 2023-08 +31.19%
BFRG 2023-09, 2023-07 +44.22%
GFGD 2023-09, 2023-08 +24.62%
ABVCthis month too 2023-08, 2023-07 +44.98%
MRKR 2023-08, 2023-07 +25.75%
INOD 2023-08, 2023-07 +24.56%

What the board was made of

Price before the move

Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.

When the announcement landed

  • Pre-market60.0%
  • Intraday8.0%
  • After hours32.0%

Volume against normal

  • Under 5x18 events, 18.2%
  • 5x to 20x27 events, 27.3%
  • Over 20x54 events, 54.5%

1 event has too little trading history for a relative volume, and is not in the tiers above.

Industry

  • Pharmaceutical preparations26 events, 26.0%
  • Biological products (excluding diagnostic substances)8 events, 8.0%
  • Prepackaged software3 events, 3.0%
  • Surgical & medical instruments & apparatus3 events, 3.0%
  • Advertising2 events, 2.0%
  • Beverages2 events, 2.0%

28 other industries, 33 events

Industry not known: 23.0%

1 event on this board carries the flag for a move that ran against its own release, too few to say whether the flag predicts anything.

Against September 2023

100 events from September 2023 in the comparable window.

September 2023 median +28.0%, selected from the 5,627 events in that month's eligible pool.

October 2023 median +28.9%, 0.9 points above September 2023. October 2023's median is taken over the 100 ranked rows, selected from the 8,103 events in that month's eligible pool.

The two windows drew on pools of very different size, so part of the gap between the medians is how deep into each pool the top hundred reaches rather than how severe the moves were.

How this ranking is measured

Close-to-close change on the measured trading session, against the previous close.

  • An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
  • One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
  • A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
  • No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.

Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.

Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.

Market cap is not shown on months older than a year, because only today's figure exists.

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

This archive starts at 2020-04, the first month with ranked moves.